IRIDEX CorporationIRIXNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR+8.6%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
+8.6%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
PeriodValue
Q3 202511.60%
Q2 2025-0.57%
Q1 2025-21.29%
Q4 2024-14.32%
Q3 2024-13.46%
Q2 2024-2.28%
Q1 2024-9.33%
Q4 20239.93%
Q3 2023-16.48%
Q3 20235.49%
Q2 202320.62%
Q4 2022-14.05%
Q4 2022-12.23%
Q3 2022-9.17%
Q2 2022-5.66%
Q4 202125.45%
Q4 20216.94%
Q3 202143.52%
Q2 202131.34%
Q4 20202.07%
Q3 20207.68%
Q2 202012.24%
Q1 2020-8.76%
Q4 2019-21.75%
Q3 20198.40%
Q2 2019-3.03%
Q1 201912.44%
Q4 2018-25.85%
Q3 201827.52%
Q2 2018-18.39%
Q1 2018-13.62%
Q4 2017-10.50%
Q3 2017-6.54%
Q3 20172.14%
Q2 201710.16%
Q4 20168.12%
Q4 2016-9.77%
Q3 20162.43%
Q2 201611.94%
Q4 2015-1.86%